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Abstract
Background:  The impact of infections with the human cytomegalovirus (HCMV) for the
development of atherosclerosis and restenosis is still unclear. Both a clear correlation and no
correlation at all have been reported in clinical, mostly serological studies. In our study we
employed a human non-injury ex vivo organ culture model to investigate the effect of an in vitro
permissive HCMV-infection on cell proliferation and neointimal hyperplasia for a period of 56 days.
Results: During routine-nephrectomies parts of renal arteries from 71 patients were obtained and
prepared as human organ cultures. Cell free HCMV infection was performed with the fibroblast
adapted HCMV strain AD169, the endotheliotropic strain TB40E, and a clinical isolate (AN 365).
After 3, 7, 14, 21, 28, 35, and 56 days in culture staining of HCMV-antigens was carried out and
reactive cell proliferation and neointimal thickening were analysed. Successful HCMV-infection was
accomplished with all three virus strains studied. During the first 21 days in organ culture no cell
proliferation or neointimal hyperplasia was detected. At day 35 and day 56 moderate cell
proliferation and neointimal hyperplasia was found both in HCMV-infected segments and mock
infected controls. Neointimal hyperplasia in productively HCMV-infected segments was lower than
in non infected at day 35 and day 56, but relatively higher after infection with the endotheliotropic
TB40E in comparison with the two other strains.
Conclusion: The data do not support the hypothesis that HCMV-infection triggers restenosis via
a stimulatory effect on cell proliferation and neointimal hyperplasia in comparison to non infected
controls. Interestingly however, even after lytic infection, a virus strain specific difference was
observed.
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Background
The role of infection with the human cytomegalovirus
(HCMV) for the development of atherosclerosis and rest-
enosis is still unclear. On one hand HCMV DNA was
detected in human atherosclerotic vessel walls and in res-
tenotic lesions [1,2] and a possible role of HCMV-infec-
tion for restenosis following angioplasty has been
discussed [3]. On the other hand conflicting data have
been reported from clinical restenosis trials: both a clear
correlation [4,5] and no correlation at all have been
reported in medium sized clinical studies [6,7]. These
studies were based predominantly on HCMV serological
data.
A number of critical problems do exist in the field of
HCMV research. HCMV replication is restricted to human
cells and significant differences exist between HCMV in
humans and animal cytomegalovirus models [8]. For that
reason data of rat cytomegalovirus infection [9,10] are of
limited significance for the human situation. There is no
model supporting true HCMV latency in vitro and finally
available HCMV strains differ significantly in cell tropism.
Especially the widely used laboratory strain AD 169 is
highly fibroblast adapted and does not replicate in
endothelial cells. In order to obtain suitable data on the
effect of HCMV-infection in humans a human model is
compulsory. Recently a human ex vivo organ culture
model (HOC-model) has been introduced by our group
to study the effect of angioplasty on cell proliferation and
neointimal hyperplasia [11] for a period of 56 days. In
humans and animal models of atherosclerosis, restenosis,
and organ transplantation, injury appears to be a critical
first step in the acceleration of vascular disease by HCMV.
However in order to maintain clear control of the ex vivo
model the authors decided to use a human non-injury
HCMV model. A corresponding model has been used suc-
cessfully to study a long lasting productive HCMV infec-
tion [12]. In the current study we employed this non-
injury human ex vivo model [12] to investigate the effect
of HCMV on cell proliferation and neointimal hyperpla-
sia up to 56 days after infection. Nevertheless is has to be
kept in mind that it is rather difficult to define a correct
and relevant control for a lytically infected organ culture
system.
Results
Direct visualization of HCMV early antigen
For detailed information of the time course and localiza-
tion of the infection staining of HCMV early antigen was
studied at day 3, 7, 14, 21, 28, 35, and 56 in the plaque-
intima, media and adventitia. Productive infection of
HOCs was successful with all three strains tested. HCMV
early antigen was first detected in the adventitia, thereafter
in the plaque-intima and finally in the media.
In extensive kinetic analyses we have shown before [12]
that infection with TB40E was slower in comparison to
AD169. At day 21 after infection, however, infection was
comparable and the area under curve of virus production
was almost identical. After infection with TB40E (Fig. 1A–
C) endothelial cells became infected more efficiently
whereas AD169 (Fig. 1D–F) infected intimal smooth
muscle cells [12]. The early productive infection of adven-
titial cells is probably an artifact of this model in compar-
ison to the in vivo situation.
Effect of HCMV-infection on cell proliferation
Proliferative response in the neointima, plaque-intima,
and media was analyzed at day 3, 7, 14, 21, 28, 35, and 56
(Fig. 2).
In the neointima (Fig. 2A) both in HCMV-infected seg-
ments and mock infected controls almost no cell prolifer-
ation was found during the first 21 days in culture, except
a very modest proliferation at day 7 in mock infected con-
trols (1.1% ± 2.4%). In mock infected controls cell prolif-
eration was increased at day 35 and day 56, 1.5% ± 2.9%
(day 35) and 6.0% ± 9.9% (day 56) proliferating cells
were detected. In HCMV-infected segments a similar result
Human organ cultures with double stainings against HCMV- antigens and von Willebrand factor (identification of  endothelial cells) or smooth muscle α-actin (identification of  smooth muscle cells) Figure 1
Human organ cultures with double stainings against HCMV-
antigens and von Willebrand factor (identification of 
endothelial cells) or smooth muscle α-actin (identification of 
smooth muscle cells). The endotheliotropic character of 
TB40E is demonstrated by the presence of HCMV early anti-
gen after 3, 14, and 21 days (big arrow; A, B, C) within von 
Willebrand positive cells (small arrow); no smooth muscle α-
actin positive cells are found in the area of the TB40E-virus 
(day 14; B). The tropism of AD169 as fibroblast adapted 
strain to smooth muscle cells is demonstrated by the pres-
ence of HCMV early antigen (big arrow; D, E, F) within α-
actin positive cells (small arrow); no positive stainings against 
von Willebrand factor are found in the area of the AD169-
virus (day 7; D).
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was found after incubation with HCMV-strains AD169
and TB40E. Proliferating cells were detected in 1.9% ±
5.6% (day 35) and 3.1% ± 6.6% (day 56) after infection
with strain AD169 and in 3.2% ± 4.6% (day 35) and 3.7%
± 8.0% (day 56) after infection with strain TB40E. Inter-
estingly, although HCMV infection is cell destructive in
vitro at day 35 the number of proliferating cells was even
increased in organ cultures infected with TB40E and
AD169 in comparison to mock infected controls. Incuba-
tion with AN365 did not trigger cell proliferation at day
35 and day 56.
In the plaque-intima a similar result was found (Fig. 2B).
Very little cell proliferation was detected both in HCMV-
infected segments and mock infected controls during the
first 21 days in culture. Cell proliferation in the plaque-
intima of mock infected controls was increased at day 35
and day 56, 2.3% ± 4.2% (day 35) and 2.3% ± 6.3% (day
56) proliferating cells were detected. In HCMV-infected
segments similar results were detected after incubation
with AN365 and TB40E, the number of proliferating cells
was 3.5% ± 7.4% and 2.1% ± 3.6% (AN365) and 2.6% ±
6.7% and 1.7% ± 2.8% (TB40E). After incubation with the
non endotheliotropic strain AD169 cell proliferation at
day 35 and day 56 was increased 3.8 times and 3.5 times
(p = 0.01) in comparison to mock infected controls, 8.8%
± 16.3% (day 35) and 8.0% ± 7.1% (day 56) proliferating
cells were detected.
In the media of HCMV-infected segments and mock
infected controls a similar effect was seen, no matter
whether the segments were analyzed at day 3, 7, 14, 21,
28, 35, and 56: no proliferation at all respectively very
small rates of proliferation were detected.
Effect of HCMV-infection on neointimal thickening
Neointimal thickening was analyzed at day 3, 7, 14, 21,
28, 35, and 56 after HCMV infection (Fig. 3). As described
earlier by our group [11], preparation procedures trig-
gered neointimal thickening in untreated controls. In
uninfected controls no neointima was identified at day 3
and day 7, first very small areas of neointima were found
at day 14 and day 21. Neointimal hyperplasia was
increased 7.4-fold at day 35 (Fig. 3) and 16.2-fold at day
56 in comparison to neointimal thickening at day 14 (Fig.
3).
After infection with HCMV strains AN365, AD169, and
TB40E similarly no or very little neointimal thickening
was detected during the first 21 days. At day 35 and day 56
after infection very small areas of neointimal thickening
were found. After infection with AN365 neointimal thick-
ening was clearly reduced in comparison to mock infected
controls. After infection with strain AD169 and TB40E
neointimal thickening was also reduced in comparison to
mock infected controls. Interestingly, at day 56 neointi-
mal thickening was pronounced after infection with
TB40E in comparison to AD169 and AN365.
Neointimal thickening in human organ cultures up to 56 days  after infection with HCMV-strains AN365, AD169, or TB40E Figure 3
Neointimal thickening in human organ cultures up to 56 days 
after infection with HCMV-strains AN365, AD169, or 
TB40E.
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Number of proliferating cells in the neointima (A) and 
plaque-intima (B) of human organ cultures up to 56 days after 
infection with HCMV-strains AN365, AD169, and TB40E (** 
= p = 0.01).
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Effect of HCMV-infection on staining against von 
Willebrand factor and smooth muscle α-actin
Staining of von Willebrand factor in the intima of HOCs
was always positive between day 3 and day 56. There was
no difference whether HOCs had been infected with
HCMV or not.
Positive staining of HOCs against smooth muscle α-actin
was always detected between day 3 and day 56, independ-
ent of whether plaque-intima or media was analyzed. No
staining of smooth muscle α-actin was found in the
neointima. No differences were detected between HCMV-
infected organ cultures and uninfected controls.
Discussion
The present study investigates the effect of HCMV-infec-
tion on reactive cell proliferation and neointimal thicken-
ing in a non-injury human organ culture model for a
period of 56 days. In accordance with a recent report of
Reinhardt et al. [12] the non injury organ culture model
was successfully infected with all three HCMV-strains
studied. Therefore this human ex vivo model can be
applied for studies of HCMV-infection without the clear
restrictions of data produced in animal studies.
The possible molecular mechanisms for the development
of vascular disease after HCMV infection is not entirely
clear. Streblow et al. [13] reported that the HCMV chem-
okine receptor US28 may be a potential target in vascular
disease. The authors demonstrated that HCMV infections
mediates in vitro migration of smooth muscle cells, which
was dependent on expression of US28. Reinhardt et al.
reported that HCMV infection of human vascular smooth
muscle cells leads to enhanced expression of a function-
ally intact PDGF beta receptor [14] and to reduced expres-
sion of extracellular matrix proteins [15]. Recently the
group of Stassen et al. (review; [16]) suggested that
immune activation following cytomegalovirus infection
might be more important than direct viral effects. Despite
all these possible mechanisms and alternative pathways
the current study investigated the direct effects of HCMV
infection in a non injury organ culture model.
HCMV early antigen was first detected in the adventitia,
subsequently in the intima and finally in the media. Chen
and colleagues [17] reported that HCMV antigen was pre-
dominantly found in the inner parts of the vessel wall and
were rarely detected in the outer layers. It is obvious that
in the human ex vivo organ culture model an atypical
path of infection was caused by the cellfree HCMV-infec-
tion technique applied. Organ cultures are surrounded by
HCMV-infected culture medium and the adventitial side
is the largest surface that is presented to the medium.
It has to be noted that it is difficult to generate a relevant
control for the infected organ culture system. The formally
correct control by an uninfected system neglects the fact
that the cell destroying lytic virus infection induced after
high titre exogenous in vitro infection causes an addi-
tional cell damaging effect. This situation is probably
rather different from the in vivo situation with alternating
latent states of infection and local recurrences.
In comparison to mock infected controls HCMV-infection
did not stimulate cell proliferation and neointimal thick-
ening. At first sight these data do not support the hypoth-
eses that HCMV-infection triggers restenosis, as might
have been concluded from experimental data [1-3] and
the correlation between HCMV-infection and restenosis
in some clinical studies [4,5]. The cell proliferation in
mock infected controls was probably caused by the prep-
aration procedures that have to be carried out in all organ
culture segments [11]. Although cell proliferation was not
increased after HCMV-infection, it remains unclear why
some cell proliferation was found after infection with
strain AD169 and TB40E but no proliferation at all was
detected after infection with strain AN365.
After infection with all three HCMV strains studied
neointimal hyperplasia was reduced after 35 and 56 days,
reaching statistical significance after day 56. In the case of
HCMV strain AN365 the chain of events seems to be
understandable, a maximal inhibition of cell proliferation
at day 35 caused a significant inhibition of neointimal
thickening at day 56. After infection with the HCMV
strains AD169 and TB40E however, the significant inhibi-
tion of neointimal thickening cannot be explained by an
inhibition of cell proliferation. Apart from the contrasting
pathways that may have been activated in the organ cul-
ture cultures by HCMV-infection [18,19] the high amount
of virus applied has to be discussed critically. It is possible
that the high amounts of HCMV caused a direct inhibitory
effect on intimal hyperplasia. Reinhardt et al. [12] applied
high concentrations of HCMV in an identical experimen-
tal setting and reported of a productive HCMV-infection
even at day 56 after infection, indicating the vitality of the
segments.
Limitations of the study
A major limitation of the model derives from the fact that
the segments are stripped off their vasa vasorum. In vivo
these vasa vasorum are in charge of supplying the vessel
wall with nutrition and oxygen. Only a relative small part
of the supply with nutrition and oxygen is delivered by
passive diffusion from both the endoluminal and the
adventitial surface. In organ culture segments the only
supply occurs by passive diffusion of the culture medium,
mainly from the adventitial side. These difficulties cause
in consequence the unphysiologic path of infection afterBMC Microbiology 2007, 7:68 http://www.biomedcentral.com/1471-2180/7/68
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cellfree HCMV infection. HCMV-infection is starting from
the adventitia and moving on to the media, before it's
finally approaching the intima. Moreover inflammatory
components are missing in the model. Several groups
have demonstrated that the acceleration of solid organ
rejection in rats requires an active inflammatory compo-
nent and without it vascular disease does not occur.
During careful surgical extraction all artery segments are
treated in the same way according existing standards. All
segments are clamped, cautered and cut at the frontal
sides. In the laboratory the adventitial side of all segments
is further prepared, causing again considerable damage to
the vessel. These complex manipulations of all segments
cause high standard deviations.
The development of vascular disease, especially athero-
sclerosis, has been linked to the negative effects of turbu-
lent flow. The model would mimic more closely the in
vivo situation if studied in flow conditions. Although first
experiences with a human perfused organ culture model
have been published by our group [20], HCMV-infection
in a perfused human ex vivo model has not yet been
reported.
The CMV-status of the donors was not checked in the cur-
rent manuscript. Reinhardt et al. [12] demonstrated in a
similar experimental study design that the level of serop-
ositivity was 60%. However the serostatus of the donor
did not influence the kinetic and amount of HCMV-infec-
tion in the renal artery segments [12].
Although the authors would like to point out that it is
extremely important to model human vascular disease
using human tissues and human viruses, due to the limi-
tations of the model a negative result may not truly reflect
the natural host:virus complexity.
Conclusion
The human ex vivo organ culture model was successfully
infected with all three HCMV-strains studied. Therefore
the model is a suitable basis for further studies of HCMV-
infection, without the problems arising from data describ-
ing HCMV infection in animal models.
The results of the current study do not support the
hypothesis that HCMV-infection might stimulate the rest-
enosis process by activation of cell proliferation and
neointimal hyperplasia. However in future studies the
issue of an inhibitory effect of high HCMV-levels on oth-
erwise stimulated pathways should be addressed. HCMV-
infection in a perfused human organ culture model [20]
would more closely mimic the route of infection in vivo.
Methods
Preparation and cultivation of human organ cultures
During routine-nephrectomies parts of renal arteries of 71
patients were extracted (male/female: 37/32; mean age:
61.1 years ± 15.4 S.D.). Cylindric segments with a side
length of 5 mm were cut from the artery segments. Imme-
diately after preparation, cylinders were transferred as
HOCs into sterile HEPES-buffered (15 mmol/L) culture
medium (DMEM) without serum supplement.
Cell free HCMV infection of human organ cultures
For cell free HCMV infection of HOC-segments the labo-
ratory strain AD169, a clinical isolate AN365 and the
endotheliotropic strain TB40E were used. Infection of
HOC-segments was carried out for 12 h as described by
Reinhardt et al. [12] with 5 × 105 plaque forming units
(PFU) of HCMV-strain AD169 and 1 × 105 PFU of the
HCMV strains AN365 and TB40E. After infection with
AD169 a reduced amount of HCMV was detected in the
culture medium in comparison to the amount of virus
after infection with AN365 and TB40E [12]. Therefore an
increased amount of AD169 was used in the current study.
Infection was carried out in low volume using high titered
viral stocks that had been produced in fibroblasts [12].
After cell free infection HOCs were carefully washed in
phosphate buffered saline (PBS+). As controls HOC-seg-
ments without viruses were incubated with the identical
sucrosephosphate buffer used for the virus stocks (mock).
Cultivation and fixation of human organ cultures
HOCs were cultured in a mixture of Waymouth's MB 752/
1 and Ham F12 nutrient mixture (1:1 v/v; Bio Whittaker,
Verviers, B) supplemented with 15% fetal calf serum (PAA
Laboratories, Cölbe, D) at 37°C in 5% CO2. The culture
medium was exchanged every second or third day. At day
3, 7, 14, 21, 28, 35, and 56 HOCs were washed with PBS+,
fixed in 4% buffered paraformaldehyde (Merck, Darm-
stadt, D) and embedded in paraffin. The specimens were
cut in series at 4 µm thickness.
Morphometry of human organ cultures after HCMV-
infection
For histological examination deparaffinized sections were
stained with an elastica-van Gieson staining (Chroma,
Köngen, D). For calculation of the average arterial wall
thickening cuts from five (day 3, 7, 14, 21) respectively 10
(day 35, 56) different organ culture segments were ana-
lyzed three times for each single experiments with a com-
puterized digital image analyzer (Bioquant TM System 4 R
+ M Biometrics, Bilancy Consulting, Düsseldorf, D). Tak-
ing into account the various lumina of HOC segments, the
percentage of neointimal thickening was calculated as:
Area of neointima/Area of neointima, plaque-intima and
media × 100.BMC Microbiology 2007, 7:68 http://www.biomedcentral.com/1471-2180/7/68
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Immunohistochemistry of human organ cultures
For immunohistological staining paraffin sections were
processed using the avidin-biotin immunoperoxidase
technique [11].
As primary antibody for the detection of HCMV in HOC-
segements HCMV delayed early DNA-binding protein
p52: clone CCH2 (DAKOPATTS, Hamburg, D) was used
in a concentration of 1 µg/mL. For direct localization of
HCMV absolute numbers of HCMV-positive cells was
detected in the neointima, media, and adventitia of the
sections.
Proliferating cells were identified with PCNA (proliferat-
ing cell nuclear antigen, clone PC10, Dakopatts, Ham-
burg, D). The number of proliferating cells in the media,
plaque-intima and neointima was calculated independ-
endly as: Number of PCNA-positive cells/Total cell
number × 100. As described cuts from five respectively 10
segments were used in each single experiment at a magni-
fication of ×40.
Smooth muscle cells (SMC) were identified by positive
staining with antibodies against smooth muscle α-actin
(Renner, Darmstadt, D) at a concentration of 1 µg/mL.
Each area of the sections was evaluated at a magnification
of ×40 according the criteria: staining positive or staining
negative.
Endothelial cells (EC) in HOC sections were identified by
positive staining with antibodies against von Willebrand
factor (DAKOPATTS).
Double stainings were carried out with antibodies against
HCMV early antigen/von Willebrand factor and HCMV
early antigen/smooth muscle α-actin.
As secondary antibody a biotinylated horse-anti-mouse
antibody (Camon, Wiesbaden, D) was used in PCNA,
HCMV-, and smooth muscle α-actin-staining and a bioti-
nylated goat-anti-rabbit antibody (Camon) in von Wille-
brand staining.
Statistical analysis
Data are presented as mean ± S.D. The two-tailed U-test of
Mann and Whitney was used for determining statistical
significance of differences. Statistical significance was
accepted for P < 0.05 [11].
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